| scholarly article | Q13442814 |
| P2093 | author name string | E Wood | |
| M-J Milloy | |||
| A Simo | |||
| T Kerr | |||
| J Montaner | |||
| H Reddon | |||
| P2860 | cites work | Psychiatric issues in the management of patients with HIV infection. | Q51059836 |
| Effect of methadone treatment on incarceration rates among injection drug users. | Q51875449 | ||
| Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. | Q51931076 | ||
| Simulation study of confounder-selection strategies. | Q52884423 | ||
| Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients | Q57259633 | ||
| Determinants of HAART discontinuation among injection drug users | Q57259721 | ||
| Elevated rates of antiretroviral treatment discontinuation among HIV-infected injection drug users: implications for drug policy and public health | Q57259736 | ||
| Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world | Q57259754 | ||
| Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up | Q57259766 | ||
| Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996–2006 | Q57671707 | ||
| Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users | Q58310883 | ||
| Can HIV epidemics among injection drug users be prevented? | Q74670635 | ||
| Self-report among injecting drug users: a review | Q77462275 | ||
| Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users | Q77547560 | ||
| HIV treatment, injection drug use, and illicit drug policies | Q80581150 | ||
| Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence | Q24239965 | ||
| Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens | Q24534391 | ||
| Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival | Q28275479 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs | Q30751889 | ||
| Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users | Q33802147 | ||
| Drug use and medication adherence among HIV-1 infected individuals | Q33841530 | ||
| Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? | Q34184893 | ||
| Trust and the acceptance of and adherence to antiretroviral therapy | Q34386664 | ||
| Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users | Q34743004 | ||
| Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users | Q34754918 | ||
| Treatment of antiretroviral-drug-resistant HIV-1 infection | Q35610798 | ||
| Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview | Q36063045 | ||
| Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users | Q36065237 | ||
| Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5"). | Q36566931 | ||
| Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). | Q36906185 | ||
| Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. | Q37169588 | ||
| Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics | Q37308531 | ||
| Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. | Q37394050 | ||
| Using HIV viral load to guide treatment-for-prevention interventions | Q37976997 | ||
| Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy | Q39571037 | ||
| Modeling sources of self-report bias in a survey of drug use epidemiology | Q39714054 | ||
| Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. | Q41730905 | ||
| Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L | Q43689007 | ||
| Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver | Q43909228 | ||
| Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women | Q44831221 | ||
| Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy | Q45710860 | ||
| The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study | Q46381542 | ||
| Patient-perceived barriers to antiretroviral adherence: associations with race | Q46727140 | ||
| Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy | Q50114681 | ||
| Retention in methadone maintenance and heroin addicts' risk of death | Q50121455 | ||
| P433 | issue | 4 | |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 740-746 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | AIDS and Behavior | Q15752229 |
| P1476 | title | Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users | |
| P478 | volume | 18 |
| Q42104687 | 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response |
| Q35846704 | Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study |
| Q33795852 | Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California |
| Q36530984 | Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam |
| Q37452428 | Client Acceptability for Integrating Antiretroviral Therapy in Methadone Maintenance Therapy Clinics in Sichuan, China |
| Q35855263 | Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids |
| Q43494051 | Editorial Commentary: The Impact of Opiate Substitution Therapy and Highly Active Antiretroviral Therapy on Mortality Risk Among People Who Inject Drugs |
| Q34259367 | Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis. |
| Q36069058 | Gender differences in access to methadone maintenance therapy in a Canadian setting |
| Q28083237 | HIV treatment cascade in MSM, people who inject drugs, and sex workers |
| Q39181057 | Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment. |
| Q38747691 | Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences |
| Q40477509 | Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center. |
| Q40405818 | Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study. |
| Q47417340 | Oral fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure |
| Q36461334 | Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey |
| Q37125639 | Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study |
| Q40224452 | Positive percentages of urine morphine tests among methadone maintenance treatment clients with HIV/AIDS: a 12-month follow-up study in Guangdong Province, China |
| Q30377895 | Public health and international drug policy. |
| Q37650905 | Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies. |
| Q40042274 | Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China |
| Q60915851 | Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions |
| Q52631124 | The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs. |
Search more.